Hypothesis

During sleep the glymphatic system does not merely flush soluble waste; it actively triages synapses by clearing those marked for removal via activity‑dependent ubiquitin tagging. This synaptic triage preserves high‑efficiency connections while eliminating low‑use or maladaptive contacts, thereby sculpting network homeostasis each night. Chronic sleep disruption impairs this selective clearance, leading to accumulation of dysfunctional synapses, altered excitatory/inhibitory balance, and heightened vulnerability to neurodegeneration.

Mechanistic Rationale

• Synaptic tagging during wakefulness: Neuronal activity drives phosphorylation of postsynaptic proteins (e.g., PSD‑95, GluA1) and subsequent ubiquitination by E3 ligases such as TRIM3. Tagged synapses earmark themselves for lysosomal degradation.
• Astrocytic AQP4 polarization: Sleep‑induced interstitial expansion increases perivascular AQP4 localization, enhancing convective flow of cerebrospinal fluid (CSF) that can capture extracellular vesicles and membrane fragments shed from tagged synapses.
• Coupling to autophagy: Ubiquitinated synaptic components are engulfed by autophagosomes that accumulate during wakefulness; sleep‑dependent lysosomal fusion completes their degradation. Thus, glymphatic flow and autophagy act in concert to remove tagged synaptic material.
• Failure mode: When sleep is fragmented, AQP4 mislocalization reduces glymphatic influx, autophagosome clearance stalls, and tagged synapses persist. Persistent low‑weight synapses aberrantly potentiate circuits, promoting hyperexcitability and calcium‑mediated stress pathways that exacerbate tau phosphorylation and amyloid‑β production.

Testable Predictions

1. Synaptic‑specific tracer clearance: In mice expressing a photo‑convertible synaptic marker (e.g., Dendra2‑PSD‑95) under a CaMKII promoter, the rate of marker loss from the cortex will be higher during natural sleep than during equivalent periods of wakefulness or sleep deprivation.
2. AQP4 dependence: Conditional knockout of astrocytic AQP4 will abolish the sleep‑dependent decline in synaptic tracer signal without affecting overall CSF influx, demonstrating a selective synaptic clearance role.
3. Ubiquitination blockade: Inhibiting the E3 ligase TRIM3 with a peptide inhibitor during wakefulness will reduce the accumulation of ubiquitinated synaptic proteins and diminish the sleep‑dependent clearance of the synaptic tracer, linking tagging to glymphatic removal.
4. Network consequence: Chronic sleep fragmentation in wild‑type mice will increase the ratio of silent to active synapses (measured by paired‑pulse ratio and mEPSC frequency) and elevate cortical gamma power, indicative of excitatory imbalance.
5. Neurodegeneration link: In APP/PS1 mice, enhancing sleep‑dependent synaptic triage (via optogenetic stimulation of the locus coeruleus to boost slow‑wave activity) will reduce synaptic amyloid‑β plaques and improve memory performance compared with fragmented‑sleep controls.

Experimental Approach

• In vivo two‑photon imaging of thinned‑skull windows to track Dendra2‑PSD‑95 fluorescence before and after sleep/wake intervals.
• CSF sampling via cisterna magna puncture to quantify synaptic‑tracer peptides and ubiquitinated fragments using targeted mass spectrometry.
• Electrophysiology (whole‑cell patch) in cortical slices to assess synaptic strength and plasticity after sleep manipulation.
• Behavioral assays (novel object recognition, fear conditioning) to correlate synaptic triage efficacy with cognitive outcomes.
• Pharmacological/genetic interventions: AQP4 floxed mice crossed with Aldh1l1‑CreERT2; TRIM3‑specific shRNA delivered via AAV; chemogenetic activation of locus coeruleus neurons during sleep.

Implications

If validated, this hypothesis reframes sleep as a nightly synaptic editing session where the glymphatic system acts as a selective sculptor rather than a passive drain. It offers a mechanistic bridge between sleep quality, synaptic homeostasis, and the onset of neurodegenerative pathologies, suggesting that enhancing synaptic tagging or glymphatic flow could mitigate cognitive decline even when total sleep duration is limited.